12 doses of selexipag (uptravi) 1600 MCG

Ended Awarded Last action

Contract number
36C26223F0008
Awardee
Awarding agency
Obligated
$172,018

Award facts

Contract value 100% obligated
$172,018.16 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Lake Mary, FL 32746, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00001 $4,195
Original award $167,823

About this award

This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Actelion Pharmaceuticals US, Inc., a for-profit pharmaceutical manufacturer. The order is for 12 doses of the drug Selexipag (Uptravi) 1600 mcg, a medication used to treat pulmonary arterial hypertension. The contract has a potential value of $172,018.16 and a completion date of October 5, 2023. This award is made against Actelion's $105 million Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB), as well as a $60 million Blanket Purchase Agreement specifically for pulmonary arterial hypertension medications. Actelion has a history of providing specialized drug treatments to federal health facilities and correctional institutions through these contract vehicles. This delivery order does not have a set-aside designation.

Quick answers

Who was awarded contract 36C26223F0008?

36C26223F0008 was awarded to Actelion Pharmaceuticals US, Inc. by Veterans Integrated Service Network 22 (Veterans Health Administration) on October 6, 2022.

How much is contract 36C26223F0008 worth?

The government has obligated $172,018 on 36C26223F0008.

Is contract 36C26223F0008 an order under another contract?

Yes. 36C26223F0008 is a delivery order under 36F79719D0142, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C26223F0008 competed?

The extent of competition for 36C26223F0008 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award